Trade Associations
Here's a look at documents from national and international trade associations
Featured Stories
ZAGENO Receives Frost & Sullivan's 2025 Global Company of the Year Recognition for Excellence in Life Sciences E-commerce Leadership
SAN ANTONIO, Texas, Dec. 2 [Category: BizConsulting] -- Frost and Sullivan, a provider of market research and analysis, growth strategy consulting and corporate training services, posted the following news release:
* * *
ZAGENO Receives Frost & Sullivan's 2025 Global Company of the Year Recognition for Excellence in Life Sciences E-commerce Leadership
*
San Antonio, TX December 2, 2025 Frost & Sullivan is pleased to announce that ZAGENO has been recognized with the 2025 Global Company of the Year Recognition in the life sciences e-commerce industry for its outstanding achievements in digital
... Show Full Article
SAN ANTONIO, Texas, Dec. 2 [Category: BizConsulting] -- Frost and Sullivan, a provider of market research and analysis, growth strategy consulting and corporate training services, posted the following news release:
* * *
ZAGENO Receives Frost & Sullivan's 2025 Global Company of the Year Recognition for Excellence in Life Sciences E-commerce Leadership
*
San Antonio, TX December 2, 2025 Frost & Sullivan is pleased to announce that ZAGENO has been recognized with the 2025 Global Company of the Year Recognition in the life sciences e-commerce industry for its outstanding achievements in digitalinnovation, customer value enhancement, and strategic market execution. This recognition highlights ZAGENO's consistent leadership in driving measurable outcomes, strengthening its global position, and delivering customer-centric innovation in a rapidly evolving life sciences landscape.
Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: visionary innovation & performance and customer impact. ZAGENO excelled in both, demonstrating its ability to align strategic initiatives with market demand while executing with scale, precision, and operational efficiency. " ZAGENO aligns closely with key technology trends shaping the life sciences industry by combining upstream integration, AI-driven automation, and personalized user experiences. The platform positions itself early in the procurement process, capturing product data directly from experiments through integrations with electronic lab notebooks and workflow automation tools," said Amartya Bose, Senior Consultant at Frost & Sullivan.
Guided by a long-term growth strategy focused on digital innovation, global expansion, and deep customer partnerships, ZAGENO has demonstrated strong adaptability in a fast-changing market environment. The company's continued investment in data-driven procurement intelligence and automation has enabled it to scale effectively across global biotechnology and pharmaceutical markets.
Innovation remains central to ZAGENO's operating model. Its AI-powered, end-to-end procurement platform consolidates millions of SKUs, streamlines workflows, and enhances decision-making across lab, procurement, and finance teams. The platform offers enterprise-grade flexibility, scalability, and performance. "We are honored to receive Frost & Sullivan's 2025 Global Company of the Year Recognition," said Florian Wegener, Co-Founder and CEO of ZAGENO. "This acknowledgement underscores our belief that scientists, lab operations, and procurement teams deserve consumer-grade digital experiences that also meet the highest standards for compliance, data quality, and savings. By unifying millions of products, AI-driven guidance, and deep integrations into one platform, we help our customers accelerate R&D while making every dollar of lab spend work harder."
ZAGENO's unwavering commitment to customer experience further strengthens its market differentiation. By enabling seamless onboarding, supporting self-service procurement through a consumer-like interface, and maintaining high levels of platform reliability, the company delivers predictable, high-value outcomes for global life sciences organizations. Its customer-first engagement model, sustained support infrastructure, and localized partnership network have been instrumental in delivering long-term value across diverse customer segments.
Frost & Sullivan commends ZAGENO for setting a high standard in competitive strategy, execution, and market responsiveness. The company's vision, innovation roadmap, and customer-centric culture continue to shape the future of the life sciences e-commerce industry while driving tangible operational and financial impact for clients worldwide.
Each year, Frost & Sullivan presents the Company of the Year Recognition to a company that demonstrates outstanding strategy development and implementation, resulting in measurable improvements in market share, customer satisfaction, and competitive positioning. The recognition honors organizations that are redefining their industries through bold innovation, strategic excellence, and forward-looking leadership.
About ZAGENO
ZAGENO is the leading R&D lab supply procurement platform, bringing together Guided Buying, a Single-Entry Point (SEP), and AI-driven insights to streamline how scientists and procurement teams' work. Researchers access 40M+ SKUs from 5,000+ brands with real-time availability, while procurement teams execute supplier strategies, consolidate orders, and enforce compliance. With fully automated source-to-pay workflows, ZAGENO removes manual work and maverick spendsaving money, saving time, and accelerating R&D through its industry-first Metacart and One-Creditor Model. Learn more at www.zageno.com.
Contact:
Stephanie Harold
E: stephanie.harold@zageno.com
About Ashley Shreve
Marketing Coordinator - Best Practices Recognition
Ashley.Weinkauf@frost.com@frost.com
Phone: +1.210.844.2505
View all posts by Ashley Shreve
Next Post -
Ashley Shreve
Marketing Coordinator - Best Practices Recognition
Ashley.Weinkauf@frost.com@frost.com
Phone: +1.210.844.2505
***
Original text here: https://www.frost.com/news/press-releases/zageno-receives-frost-sullivans-2025-global-company-of-the-year-recognition-for-excellence-in-life-sciences-e-commerce-leadership/
U.S. POINTER Structured Healthy Lifestyle Program -- Previously Shown to Improve Cognition -- May Also Improve Sleep Apnea, Blood Pressure Regulation and Cognitive Resilience
CHICAGO, Illinois, Dec. 2 [Category: Health Care] -- The Alzheimer's Association posted the following news release:
* * *
The U.S. POINTER Structured Healthy Lifestyle Program -- Previously Shown to Improve Cognition -- May Also Improve Sleep Apnea, Blood Pressure Regulation and Cognitive Resilience
*
Two-year lifestyle intervention "recipe" tested in three NIH-funded ancillary studies
Key Takeaways
* Findings from three NIA-funded ancillary studies to the U.S. POINTER trial described beneficial effects as measured by brain imaging, sleep health, and blood pressure regulation.
* The
... Show Full Article
CHICAGO, Illinois, Dec. 2 [Category: Health Care] -- The Alzheimer's Association posted the following news release:
* * *
The U.S. POINTER Structured Healthy Lifestyle Program -- Previously Shown to Improve Cognition -- May Also Improve Sleep Apnea, Blood Pressure Regulation and Cognitive Resilience
*
Two-year lifestyle intervention "recipe" tested in three NIH-funded ancillary studies
Key Takeaways
* Findings from three NIA-funded ancillary studies to the U.S. POINTER trial described beneficial effects as measured by brain imaging, sleep health, and blood pressure regulation.
* TheU.S. POINTER recipe, a 2-year multicomponent healthy lifestyle intervention with regular structured support, improved blood pressure regulation of blood flow to the brain, reduced sleep apnea respiratory events, and increased cognitive resilience for adults with certain Alzheimer's-related brain changes.
SAN DIEGO, Dec. 2, 2025 A two-year multicomponent healthy lifestyle intervention with regular, structured support which has already shown that it can improve cognition in adults at risk for cognitive decline may also improve blood pressure regulation and reduce hourly sleep apnea respiratory events, according to new data reported today at CTAD 2025 in San Diego. The intervention may also protect against the negative cognitive effects of certain Alzheimer's disease-related brain changes.
The healthy lifestyle recipe was created for the Alzheimer's Association's U.S. POINTER trial, which published its initial results in JAMA last July and reported them at AAIC 2025. The evidence-based multicomponent lifestyle intervention adapted for the U.S. population consists of regular physical exercise, the MIND diet, cognitive challenge through computerized training and other intellectual and social activities, and regular review of health metrics and goal-setting with a study clinician.
"These studies tell us that the U.S. POINTER lifestyle intervention with structured support has substantial and significant health benefits beyond improving cognition and the benefits are in areas known to lower risk of cognitive decline and dementia," said Maria C. Carrillo, Ph.D., Alzheimer's Association chief science officer and medical affairs lead. "This positive relationship may multiply the beneficial impact of closely adhering to the structured U.S. POINTER 'recipe.'"
"Bottom line, we now have a more comprehensive picture of how the U.S. POINTER intervention affects brain health, and overall health, too," Dr. Carrillo added.
There were two versions of the intervention structured and self-guided that differed in intensity, structure, accountability and support provided. Trial participants in the structured intervention showed greater improvement on global cognition compared to the self-guided intervention, a benefit that likely reflects slowing of cognitive aging by one to two years.
Poor regulation of blood flow to the brain and sleep problems/irregular sleep patterns are known risk factors for cognitive decline and dementia, including Alzheimer's disease, so these new results describe additional benefits of the U.S. POINTER structured intervention.
The new data reports came from a series of U.S. POINTER ancillary studies funded by the NIH's National Institute on Aging (NIA):
* The U.S. POINTER Sleep Ancillary Study: POINTER-zzz
* The U.S. POINTER Neurovascular Ancillary Study: POINTER-NV
* The U.S. POINTER Neuroimaging Ancillary Study: POINTER-Neuroimaging
A fourth ancillary study, The POINTER-Microbiome Study, which presented a poster at CTAD 2025, will report more fully at a later date.
NIA Director, Dr. Richard Hodes said, "I am very encouraged by these early findings from the U.S. POINTER ancillary studies, which offer valuable insights into the physiological mechanisms that may have contributed to the positive results of the U.S. POINTER trial. The forthcoming publications and continued analysis of this rich dataset will deepen our understanding of how multimodal interventions can support brain health."
"These studies provide an unprecedented opportunity to better understand the impact that healthy lifestyle changes can have on overall health and risk for cognitive decline and dementia," said Dr. Kristina McLinden, Program Officer at NIA.
POINTER-zzz
In older adults, sleep disorders are highly prevalent, frequently undetected or untreated, and associated with poor brain health outcomes, including cognitive decline. This highlights sleep as a modifiable risk factor for Alzheimer's and other diseases that cause dementia. Interventions that improve sleep may also improve cognitive function in older adults. Two components of the U.S. POINTER's structured intervention are physical activity and healthy diet, both of which have been shown to improve overall sleep health.
The POINTER-zzz study examined whether the lifestyle changes might improve sleep quality in a subset of 780 adults who participated in the U.S. POINTER clinical trial. Nearly 65% of the study group had at least mild sleep apnea when they started the study. POINTER-zzz used simple sleep tests that were completed at home. The tests involve wearing watch-like devices overnight to measure sleep apnea, restlessness and other sleep disruptions.
Respiratory disturbances from sleep apnea declined by 1 to 2 events per hour of sleep for study participants in the structured intervention versus those in the self-guided group.
"We are excited about this finding, as it shows that the structured intervention improves not only cognition but also other behaviors that affect brain health, which may increase protection against dementia," said Laura D. Baker, Ph.D., Professor, Internal Medicine and Public Health Sciences; and Associate Director, Wake Forest Alzheimer's Disease Research Center at the Wake Forest University School of Medicine, Winston Salem, NC. "The positive effect of the structured intervention on sleep deepens the significance of the U.S. POINTER trial results for older Americans." Dr. Baker is one of the Principal Investigators of the parent trial and Principal Investigator of the sleep ancillary study.
POINTER-NV
Adequate blood flow to the brain is necessary to maintain a constant supply of oxygen and nutrients. While the relevance of reduced blood flow to the brain in Alzheimer's disease and related dementias is well documented, few studies have investigated how vascular health is essential for regulation of blood flow in the brain; this was the primary focus of the neurovascular ancillary study.
POINTER-NV enrolled 491 parent trial participants who completed comprehensive testing of vascular health at baseline, month 12, and month 24. Several types of procedures, such as ultrasound and continuous blood pressure monitoring, were used to measure the structure and function of the blood vessels in the body and in the brain.
Many POINTER-NV participants have issues that strain the heart and blood vessels, like clogged arteries, stiff arteries, or drops in blood pressure when they stand up. The researchers found significant benefits from the structured intervention on the cardiovascular system and its ability to respond to sudden changes in blood pressure, indicating improved blood pressure regulation, compared to the self-guided group. The structured intervention also improved several measures of blood-vessel health in the body's largest artery and the main arteries supplying the brain.
"Our findings indicate that a structured multidomain lifestyle intervention can improve the body's ability to regulate blood pressure, which is crucial for proper brain blood flow to the brain. Improved blood pressure regulation can also reduce aging-related vascular changes that allow harmful, pulsing flow of blood too fast and too much into the brain. These benefits may help to support cognitive function and overall brain health in U.S. POINTER participants," said ancillary study Principal Investigators, Drs. Brinkley and Shaltout.
POINTER-Neuroimaging
POINTER-Neuroimaging is the first large-scale investigation of how lifestyle interventions affect biological markers of Alzheimer's and dementia in the brain. Trial participants from all five main study sites were invited to receive MRI and Ab and tau positron emission tomography (PET) imaging to assess the effects of the U.S. POINTER intervention on brain health, including (1) brain imaging biomarkers of Alzheimer's and cerebrovascular disease and (2) cognitive benefits that were influenced by these biomarkers.
POINTER-Neuroimaging enrolled roughly 50% of the parent trial participants. The researchers found that people in the study with certain Alzheimer's-related brain changes lower hippocampal volume or higher tau protein build up had greater cognitive benefits from the structured lifestyle intervention than those with these brain changes in the self-guided group. However, the presence, absence or level of amyloid in the brain did not impact the amount of cognitive benefit.
"Participating in the U.S. POINTER study's structured intervention protected against the negative effects of tau tangle build up or smaller baseline hippocampal volume," said Dr. Susan Landau, Principal Investigator of the ancillary study. "In other words, people with certain at-risk brain characteristics saw greater cognitive benefits following the intervention, but amyloid build up the primary biomarker that defines Alzheimer's disease was not one of those at-risk characteristics. This means that people with amyloid build up experience the same benefits from the intervention as those without amyloid."
The U.S. POINTER ancillary studies are supported by the following NIH grants:
* POINTER-zzz: R01AG064440
* POINTER-NV: R01AG066910
* POINTER-Neuroimaging: R01AG062689
* POINTER-Microbiome: U19AG063744
About the Alzheimer's Association
The Alzheimer's Association is a worldwide voluntary health organization dedicated to Alzheimer's care, support and research. Our mission is to lead the way to end Alzheimer's and all other dementia by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia(r). Visit alz.org or call 800.272.3900.
***
Original text here: https://www.alz.org/news/2025/us-pointer-healthy-lifestyle-program-may-improve-sleep-apnea-blood-pressure-cognitive-resilience
NYC Health + Hospitals/South Brooklyn Health Appoints Selwena R. Brewster, MD, MBA As Chief Medical Officer
NEW YORK, Dec. 2 [Category: Health Care] -- The New York Health and Hospitals posted the following news release:
* * *
NYC Health + Hospitals/South Brooklyn Health Appoints Selwena R. Brewster, MD, MBA As Chief Medical Officer
*
Her leadership in throughput and capacity management has reduced hospital length of stay, improved operational efficiency, and ensured timely, well-coordinated care for patients
Brooklyn, NY NYC Health + Hospitals/South Brooklyn Health today announced the appointment of Selwena R. Brewster, MD, MBA as Chief Medical Officer where she will oversee clinical operations
... Show Full Article
NEW YORK, Dec. 2 [Category: Health Care] -- The New York Health and Hospitals posted the following news release:
* * *
NYC Health + Hospitals/South Brooklyn Health Appoints Selwena R. Brewster, MD, MBA As Chief Medical Officer
*
Her leadership in throughput and capacity management has reduced hospital length of stay, improved operational efficiency, and ensured timely, well-coordinated care for patients
Brooklyn, NY NYC Health + Hospitals/South Brooklyn Health today announced the appointment of Selwena R. Brewster, MD, MBA as Chief Medical Officer where she will oversee clinical operationsto ensure high-quality patient care and the continued strategic success of the institution. In this role, she will lead the medical staff, develop and implement clinical policies, manage medical budgets, and ensure full compliance with state, federal, and regulatory requirements. Her appointment was effective November 7 and follows the retirement of Dr. Terence Brady earlier in 2025, after 13 years of dedicated service to South Brooklyn Health.
Dr. Brewster brings a distinguished clinical background in both Internal Medicine and Emergency Medicine, a dual foundation that allows her to bridge frontline medical practice with strategic operational leadership. Throughout her career with South Brooklyn Health and NYC Health + Hospitals, she has led transformative initiatives that strengthened clinical quality, enhanced patient outcomes, and elevated standards of care across multiple service lines. Her previous role as Associate Chief Medical Officer at NYC Health + Hospitals/Kings County further underscored her ability to effect system-wide improvements and foster collaboration across large, multidisciplinary teams.
Beyond her administrative accomplishments, Dr. Brewster is recognized as an industry expert in Quality, Risk Management, Patient Safety, Ethics, and Peer Review. She has built sustainable infrastructures that promote accountability, transparency, and continuous improvement, while guiding teams through complex reviews and quality-focused initiatives. Her leadership in throughput and capacity management has reduced hospital length of stay, improved operational efficiency, and ensured timely, well-coordinated care for patients.
In addition to her new role as Chief Medical Officer, Dr. Brewster will continue to serve as South Brooklyn Health's Interim Chief Quality Officer. She completed her medical degree at Ross University, a Residency in Internal Medicine at the University of Connecticut, and a Residency in Emergency Medicine at the University of Medicine and Dentistry of New Jersey. She is a graduate of the PAGNY Physician Leadership Program, a Certified Management Coach, and holds a Physician Executive MBA from the University of Tennessee, further reflecting her commitment to lifelong learning and leadership excellence.
MEDIA CONTACT : SBHPublicAffairs@nychhc.org
#213-25
About NYC Health + Hospitals/South Brooklyn Health
A member of NYC Health + Hospitals, NYC Health + Hospitals, South Brooklyn Health is a major health care provider in the borough of Brooklyn. Its foremost mission is to provide quality, comprehensive care to all members of the public regardless of their ability to pay. 2025 marks its 150th anniversary of serving the communities of Brooklyn. South Brooklyn Health's modern campus features the new Ruth Bader Ginsburg Hospital and full Ambulatory Care Services. Its range of services, include emergency care, surgery, maternity, and specialized outpatient care, and holds designations for its stroke and maternal care centers. NYC Health + Hospitals/South Brooklyn Health is a joint commission accredited thrombectomy stroke center, providing immediate access to the highest level of stroke care. South Brooklyn Health is also a certified Percutaneous Coronary Intervention (PCI) Center, providing the highest level of neurology and cardiology care. For more information, visit www.nychealthandhospitals.org/southbrooklynhealth.
About NYC Health + Hospitals
NYC Health + Hospitals is the largest public health care system in the nation serving more than a million New Yorkers annually in more than 70 patient care locations across the city's five boroughs. A robust network of outpatient, neighborhood-based primary and specialty care centers anchors care coordination with the system's trauma centers, nursing homes, post-acute care centers, home care agency, and MetroPlusHealthall supported by 11 essential hospitals. Its diverse workforce of more than 46,000 employees is uniquely focused on empowering New Yorkers, without exception, to live the healthiest life possible. For more information, visit www.nychealthandhospitals.org and stay connected on Facebook, Twitter, Instagram and LinkedIn.
***
Original text here: https://www.nychealthandhospitals.org/pressrelease/nyc-health-hospitals-south-brooklyn-health-appoints-selwena-r-brewster-md-mba-as-chief-medical-officer/
CMS Memo Answers Questions About State Recovery After Government Shutdown
JEFFERSON CITY, Missouri, Dec. 2 -- The Missouri Hospital Association posted the following news:
* * *
CMS Memo Answers Questions About State Recovery After Government Shutdown
The Centers for Medicare & Medicaid Services issued a memo outlining answers to questions from states and providers regarding survey, enforcement and certification recovery activities after the federal government shutdown, which took place from Oct. 1 through Nov. 12.
On Nov. 12, Congress enacted Public Law 119-37, which provided a continuing appropriation until Friday, Jan. 30, 2026, with retroactive authority back
... Show Full Article
JEFFERSON CITY, Missouri, Dec. 2 -- The Missouri Hospital Association posted the following news:
* * *
CMS Memo Answers Questions About State Recovery After Government Shutdown
The Centers for Medicare & Medicaid Services issued a memo outlining answers to questions from states and providers regarding survey, enforcement and certification recovery activities after the federal government shutdown, which took place from Oct. 1 through Nov. 12.
On Nov. 12, Congress enacted Public Law 119-37, which provided a continuing appropriation until Friday, Jan. 30, 2026, with retroactive authority backto Oct. 1, 2025. The appropriation enables states to be reimbursed for survey activities conducted during the shutdown period.
* * *
About Missouri Hospital Association
The Missouri Hospital Association is a nonprofit association in Jefferson City that represents 136 Missouri hospitals. In addition to representation and advocacy on behalf of its membership, the association offers continuing education programs on current health care topics and seeks to educate the public about health care issues.
* * *
Original text here: https://www.mohospitals.org/newsroom/cms-memo-answers-questions-about-state-recovery-after-government-shutdown
[Category: Health Care]
American Pharmacists Association (APhA) and American Academy of HIV Medicine (AAHIVM) Announce Endorsement of Pharmacy-Based HIV Prevention Services Certificate Training Program
WASHINGTON, Dec. 2 -- The American Pharmacists Association issued the following news release:
* * *
American Pharmacists Association (APhA) and American Academy of HIV Medicine (AAHIVM) announce endorsement of Pharmacy-Based HIV Prevention Services Certificate Training Program
The American Pharmacists Association (APhA) and the American Academy of HIV Medicine (AAHIVM) today announced that AAHIVM has formally endorsed the clinical and educational content of APhA's Pharmacy-Based HIV Prevention Services Certificate Training Program and Microcredential. The endorsement follows a detailed review
... Show Full Article
WASHINGTON, Dec. 2 -- The American Pharmacists Association issued the following news release:
* * *
American Pharmacists Association (APhA) and American Academy of HIV Medicine (AAHIVM) announce endorsement of Pharmacy-Based HIV Prevention Services Certificate Training Program
The American Pharmacists Association (APhA) and the American Academy of HIV Medicine (AAHIVM) today announced that AAHIVM has formally endorsed the clinical and educational content of APhA's Pharmacy-Based HIV Prevention Services Certificate Training Program and Microcredential. The endorsement follows a detailed reviewby AAHIVM subject matter experts to confirm the program meets the academy's high standards for HIV prevention and clinical excellence.
The announcement is being issued on World AIDS Day (December 1)--a global day of awareness, remembrance, and commitment to ending the HIV epidemic. The timing reflects both organizations' shared dedication to expanding access to HIV prevention services and strengthening the health care workforce that supports individuals with HIV or who have a high likelihood of acquiring it.
APhA's Pharmacy-Based HIV Prevention Services Certificate Training Program is designed to empower pharmacists with the clinical knowledge and operational tools necessary to deliver HIV prevention and sexual-wellness services. AAHIVM's endorsement reinforces its quality, relevance, and value as pharmacists expand access to HIV prevention services nationwide.
For pharmacy professionals interested in APhA's Pharmacy-Based HIV Prevention Services Certificate Training Program, please visit www.pharmacist.com/Education/Certificate-Training-Programs/Pharmacy-Based-HIV-Prevention-Services
* * *
About APhA
APhA is the only organization advancing the entire pharmacy profession. From our headquarters in Washington, DC, APhA leads the pharmacy profession by supporting pharmacists, student pharmacists, and pharmacy technicians in their role optimizing medication use and patient health outcomes and ensuring patients have access to pharmacists' care. We do this through our strong and effective advocacy, top notch education, practice tools and resources, dissemination of evidence, and opportunities for members to engage and learn from each other. APhA is the pharmacy voice at the table in developing national guidelines, policies, and best practices that advance the profession and patient care. To learn more, visit www.pharmacist.com.
About AAHIVM
AAHIVM is the nation's leading independent organization of health care professionals dedicated to providing excellence in HIV care and prevention. Our membership of practitioners and credentialed clinicians manage the health of the majority of people with and at risk of HIV in the United States.
* * *
Original text here: https://www.pharmacist.com/APhA-Press-Releases/american-pharmacists-association-apha-and-american-academy-of-hiv-medicine-aahivm-announce-endorsement-of-pharmacy-based-hiv-prevention-services-certificate-training-program
[Category: Medical]
American Academy of Sleep Medicine: Insomnia Combined With Sleep Apnea is Associated With Worse Memory in Older Women
DARIEN, Illinois, Dec. 2 (TNSjou) -- The American Academy of Sleep Medicine issued the following news release:
* * *
Insomnia combined with sleep apnea is associated with worse memory in older women
New research among older adults with sleep apnea reveals that verbal memory performance is significantly worse in women -- but not in men -- who also have insomnia.
Results show that older adults with comorbid insomnia and sleep apnea -- often referred to as COMISA -- demonstrated worse memory performance than those with sleep apnea alone. This interaction remained significant even after adjusting
... Show Full Article
DARIEN, Illinois, Dec. 2 (TNSjou) -- The American Academy of Sleep Medicine issued the following news release:
* * *
Insomnia combined with sleep apnea is associated with worse memory in older women
New research among older adults with sleep apnea reveals that verbal memory performance is significantly worse in women -- but not in men -- who also have insomnia.
Results show that older adults with comorbid insomnia and sleep apnea -- often referred to as COMISA -- demonstrated worse memory performance than those with sleep apnea alone. This interaction remained significant even after adjustingfor age, body mass index, sleep apnea severity, and education. However, when analyzed by sex, COMISA was significantly associated with worse verbal memory outcomes in women, but not in men.
"We expected that having both insomnia and sleep apnea would worsen memory for everyone, but only older women showed this vulnerability. That was striking, especially because women typically outperform men on verbal memory tasks," said lead author Breanna Holloway, who has a doctorate in clinical psychology and behavioral medicine and is a postdoctoral researcher at UC San Diego School of Medicine. "The fact that COMISA seemed to offset that advantage hints at a hidden sleep-related pathway to cognitive decline in women. Prior studies have shown increased incidence of Alzheimer's disease in women with untreated sleep apnea."
The study, "Comorbid insomnia and sleep apnea (COMISA) is associated with worse verbal episodic memory in older women (https://jcsm.aasm.org/doi/10.5664/jcsm.11902)," is published in the Dec. 1 issue of the Journal of Clinical Sleep Medicine, the official publication of the American Academy of Sleep Medicine.
The study involved 110 older adults between the ages of 65 and 83 who were diagnosed with obstructive sleep apnea. They completed an overnight sleep study and cognitive testing, and insomnia and verbal memory were assessed using validated tools. COMISA was present in 37% of participants.
According to the authors, sex differences in sleep architecture may explain the cognitive vulnerability observed in women with COMISA. Post hoc analyses revealed that women with COMISA had reduced rapid eye movement sleep and more slow wave sleep compared with men, underscoring the importance of considering sex-specific patterns when evaluating COMISA.
"These results point to an overlooked risk in women with both insomnia and sleep apnea," said Holloway. "Because women are more likely to have insomnia and often go undiagnosed for sleep apnea, recognizing and treating COMISA early could help protect memory and reduce dementia risk."
The researchers noted that the findings support sex-specific screening and treatment strategies.
Dr. Atul Malhotra, the Peter C. Farrell Presidential Endowed Chair in Pulmonary Medicine at University of California San Diego School of Medicine and pulmonologist at UC San Diego Health, was the principal investigator for this study.
Read more sleep research news from the AASM.
* * *
To arrange an interview with a study author or an AASM spokesperson, please contact media@aasm.org.
About the American Academy of Sleep Medicine
Established in 1975, the AASM is a medical association that advances sleep care and enhances sleep health to improve lives. The AASM membership includes more than 9,500 physicians, scientists, and other health care professionals who help people who have sleep disorders. The AASM also accredits 2,300 sleep centers that are providing the highest quality of sleep care across the country.
* * *
Original text here: https://aasm.org/insomnia-combined-with-sleep-apnea-is-associated-with-worse-memory-in-older-women/
[Category: Medical]
AHA, MHA and Four Safety-Net Hospitals File Suit to Stop Unlawful 340B Changes Threatening Patient Care
CHICAGO, Illinois, Dec. 2 -- The American Hospital Association issued the following news release on Dec. 1, 2025:
* * *
AHA, MHA and Four Safety-Net Hospitals File Suit to Stop Unlawful 340B Changes Threatening Patient Care
Proposed rebate program would take resources for providing care to rural, poor patients and impose significant costs and burdens on the already-strapped hospitals providing them care
*
LEWISTON, Maine -- Today, the American Hospital Association (AHA), the Maine Hospital Association (MHA) and four safety-net health systems from across the country filed a lawsuit in the United
... Show Full Article
CHICAGO, Illinois, Dec. 2 -- The American Hospital Association issued the following news release on Dec. 1, 2025:
* * *
AHA, MHA and Four Safety-Net Hospitals File Suit to Stop Unlawful 340B Changes Threatening Patient Care
Proposed rebate program would take resources for providing care to rural, poor patients and impose significant costs and burdens on the already-strapped hospitals providing them care
*
LEWISTON, Maine -- Today, the American Hospital Association (AHA), the Maine Hospital Association (MHA) and four safety-net health systems from across the country filed a lawsuit in the UnitedStates District Court for the District of Maine to stop unlawful changes to a critical program that provides lower-cost drugs to hospitals and clinics that serve rural, poor and vulnerable communities.
At a time when financially strapped hospitals are struggling to stretch their resources to care for the nation's underserved populations, the U.S. Department of Health and Human Services (HHS) is abruptly forcing health care providers to adopt new, costly changes to the 340B Drug Pricing Program. For more than 30 years, the 340B program has helped safety-net hospitals provide care to millions of people and communities in need. In 2022 alone, thanks in part to these savings, 340B hospitals provided nearly $100 billion of benefits to their communities, including free or discounted drugs for patients, comprehensive care for the uninsured, behavioral health services, opioid treatment, oncology care, food pantries and more.
Under the HHS planned change to the 340B program, safety-net providers would have to pay drug manufacturers the full market price for drugs upfront and then seek reimbursement only after the drugs are administered to patients -- a monumental shift that would impose hundreds of millions of dollars in additional annual costs and burdensome paperwork requirements on hospitals and other covered entities with no benefit to patients.
"When the government announced its new rebate program just a few months ago, it recognized that it would fundamentally shift how the 340B program has operated for more than three decades. When making such a major change, with such far-reaching consequences for patients and hospitals, it is important that the government follow the basic administrative rules of the road. Unfortunately, it did not do so here," said Rick Pollack, president and CEO of the AHA. "And giving hospitals only a few months to comply with these burdensome new requirements or risk losing millions of dollars in discounts they are entitled to under the law will harm patients and communities across the country. We are asking the court to act quickly to protect access to vital care services."
If implemented on Jan. 1, 2026, the 340B Rebate Model Pilot Program would impose overwhelming financial challenges on hospitals and providers participating in the 340B program, many of which already operate on razor thin margins while playing a vital role in their communities, often serving as the only source of care. The decision to move forward with the rebate program through a rushed, opaque process following its announcement on July 31, 2025, violates the most basic principles of administrative law and ignores the concerns of over a thousand 340B hospitals and other stakeholders, many of which highlighted the significant costs and community impact of administering the rebate model.
"Having upfront drug discounts has been a critical lifeline to our community and our ability to serve patients who otherwise wouldn't be able to access care," said Winfield S. Brown, president of St. Mary's Regional Medical Center in Lewiston, Maine. "Allowing this program to go forward despite the objections that have been raised would do irreparable harm to the patients of Androscoggin County and other communities like ours across the country."
"Maine's hospitals are already facing very difficult financial conditions as they strive to continue providing a full range of care to their communities," said Steven Michaud, president of the Maine Hospital Association. "Maine hospitals simply cannot afford the immense costs of this hastily imposed rebate program."
For more than 30 years, safety-net and rural hospitals that serve millions of Americans every year have relied on upfront drug discounts to expand access to care, make life-saving medications available, and provide critical care to vulnerable communities across America. The AHA and MHA are joined in this suit by St. Mary's Regional Medical Center in Maine, the Unity Medical Center in North Dakota, the Dallas County Medical Center in Arkansas, and the Nathan Littauer Hospital and Nursing Home in New York -- all community-based health care providers that participate in the 340B program.
* * *
About the American Hospital Association (AHA)
The American Hospital Association (AHA) is a not-for-profit association of health care provider organizations and individuals that are committed to the health improvement of their communities. The AHA advocates on behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, our clinician partners - including more than 270,000 affiliated physicians, 2 million nurses and other caregivers - and the 43,000 health care leaders who belong to our professional membership groups. Founded in 1898, the AHA provides insight and education for health care leaders and is a source of information on health care issues and trends. For more information, visit the AHA website at www.aha.org.
* * *
Original text here: https://www.aha.org/press-releases/2025-12-01-aha-mha-and-four-safety-net-hospitals-file-suit-stop-unlawful-340b-changes-threatening-patient-care
[Category: Health Care]
